ClinicalTrials HQ

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

Active, not recruiting · NCT05791201 · Registry updated 2026-10-09
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 DiabetesNutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitusActive, not recruitingPhase 1 / Phase 22026-10-09NCT05791201

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Vertex Pharmaceuticals Incorporated37

16 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Churchill HospitalOxfordUnited Kingdom17
Dresden Center for Islet TransplantationDresdenGermany2
Hopiteaux Universitaires de GeneveGenevaSwitzerland2
Hospital of the University of PennsylvaniaPhiladelphiaUnited States142
IRCCS Ospedale San RaffaeleMilanItaly47
Leiden UniversityLeidenNetherlands4
Massachusetts General HospitalBostonUnited States1015
Montreal Clinical Research InstituteMontrealCanada1
Royal Victoria InfirmaryNewcastle upon TyneUnited Kingdom10
Toronto General Hospital (TGH)TorontoCanada2
UHealth Diabetes Research InstituteMiamiUnited States2
University of Alberta, EdmontonEdmontonCanada2
University of ChicagoChicagoUnited States312
University of Pittsburgh Medical Center MontefiorePittsburghUnited States2
University of WisconsinMadisonUnited States85
Vancouver General HospitalVancouverCanada7